HPV Vaccination: Are We Meeting Our Targets in Cervical Cancer Prevention?

Beavis, Anna; Rositch, Anne F.; Krakow, Melinda; Levinson, Kimberly

doi:10.1007/s13669-017-0216-0

Curr Obstet Gynecol Rep

2017

DOI: 10.1007/s13669-017-0216-0

|View full text |Cite

HPV Vaccination: Are We Meeting Our Targets in Cervical Cancer Prevention?

Anna Beavis

Anne F. Rositch

Melinda Krakow

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2018

Publication Types

Select...

Article1

Relationship

Self Cite1

Independent0

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 72 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…As the first vaccine designed to prevent cancer, the public health potential of the HPV vaccine is substantial. Despite this promise, actual HPV vaccination rates in the United States are disappointingly low in comparison with other routine childhood vaccines, and they fall well below public health targets (2,3). According to the National Immunization Survey-Teen, only 50% of males and 63% of females had initiated the HPV vaccine series in 2015 (4).…”

mentioning

confidence: 99%

Invited Commentary: Moving From Evidence to Impact for Human Papillomavirus Vaccination—The Critical Role of Translation and Communication in Epidemiology

Rositch

Krakow

2018

American Journal of Epidemiology

Self Cite

View full text Add to dashboard Cite

In response to the accompanying article by Yih et al. (Am J Epidemiol. 2018;187(6):1269-1276), we highlight the importance of moving beyond epidemiologic research on human papillomavirus (HPV) vaccine safety to focus on translation of this strong evidence base into successful vaccine safety communication strategies to bolster vaccine uptake. The potential of the HPV vaccine to reduce cancer incidence is substantial, yet actual HPV vaccination rates in the United States are disappointingly low in comparison with other routine childhood vaccines with similar safety profiles. This is no doubt due, in part, to persistent parental safety concerns. In 2016, safety remained the second most common reason for lack of vaccination intent by parents of unvaccinated adolescents. While the strong study by Yih et al. makes use of a novel statistical method and a large medical claims database to confirm the low occurrence of adverse events following HPV vaccination observed globally, their study also highlights a key challenge for epidemiologists: translating our research findings to other public health domains, so that evidence-informed communication strategies can be used to disseminate the information in a way that is understandable and useful to the public. Moving forward, multidisciplinary research teams will be essential to ensure that our epidemiologic findings have a broad public health impact.

show abstract

mentioning

confidence: 99%

Invited Commentary: Moving From Evidence to Impact for Human Papillomavirus Vaccination—The Critical Role of Translation and Communication in Epidemiology

Rositch

Krakow

2018

American Journal of Epidemiology

Self Cite

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

HPV Vaccination: Are We Meeting Our Targets in Cervical Cancer Prevention?

Cited by 1 publication

References 72 publications

Invited Commentary: Moving From Evidence to Impact for Human Papillomavirus Vaccination—The Critical Role of Translation and Communication in Epidemiology

Invited Commentary: Moving From Evidence to Impact for Human Papillomavirus Vaccination—The Critical Role of Translation and Communication in Epidemiology

Contact Info

Product

Resources

About